Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Norton

Showing results (261-270 of 305) with videos related to

Pageof 31
Sort By:
The Lancet. Rheumatology|October 18, 2024
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort studyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
The Lancet. Rheumatology|February 8, 2025
Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' replyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
Annals of the Rheumatic Diseases|May 29, 2023
JAK inhibitors and the risk of malignancy: a meta-analysis across disease indicationsMark D Russell, Christopher Stovin, Edward Alveyn, et al.
Plos One|April 7, 2023
The use of culturally adapted and translated depression screening questionnaires with South Asian haemodialysis patients in EnglandShivani Sharma, Sam Norton, Kamaldeep Bhui, et al.
Annals of the Rheumatic Diseases|June 4, 2018
Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA studySantiago Rodrigues Manica, Alexandre Sepriano, Sofia Ramiro, et al.
The Lancet. Respiratory Medicine|November 17, 2023
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trialFrances C Hall, Joseph Cheriyan, Andrew P Cope, et al.
Rheumatology (Oxford, England)|April 27, 2018
Depressive symptoms, pain and disability for adolescent patients with juvenile idiopathic arthritis: results from the Childhood Arthritis Prospective StudyLaura Hanns, Lis Cordingley, James Galloway, et al.
Rheumatology International|December 15, 2025
Adapting to living with systemic autoimmune rheumatic diseases; a qualitative exploration of patient and clinician perspectivesAlice Tunks, Martha Piper, Sean Humfrey, et al.
The Journal of Infection|June 2, 2020
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort studyJames B Galloway, Sam Norton, Richard D Barker, et al.
Plos One|January 13, 2022
Inpatient COVID-19 mortality has reduced over time: Results from an observational cohortKatie Bechman, Mark Yates, Kirsty Mann, et al.
Pageof 31

Showing results (261-270 of 305) with videos related to

Sort By:
Pageof 31
The Lancet. Rheumatology|October 18, 2024
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort studyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
The Lancet. Rheumatology|February 8, 2025
Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' replyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
Annals of the Rheumatic Diseases|May 29, 2023
JAK inhibitors and the risk of malignancy: a meta-analysis across disease indicationsMark D Russell, Christopher Stovin, Edward Alveyn, et al.
Plos One|April 7, 2023
The use of culturally adapted and translated depression screening questionnaires with South Asian haemodialysis patients in EnglandShivani Sharma, Sam Norton, Kamaldeep Bhui, et al.
Annals of the Rheumatic Diseases|June 4, 2018
Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA studySantiago Rodrigues Manica, Alexandre Sepriano, Sofia Ramiro, et al.
The Lancet. Respiratory Medicine|November 17, 2023
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trialFrances C Hall, Joseph Cheriyan, Andrew P Cope, et al.
Rheumatology (Oxford, England)|April 27, 2018
Depressive symptoms, pain and disability for adolescent patients with juvenile idiopathic arthritis: results from the Childhood Arthritis Prospective StudyLaura Hanns, Lis Cordingley, James Galloway, et al.
Rheumatology International|December 15, 2025
Adapting to living with systemic autoimmune rheumatic diseases; a qualitative exploration of patient and clinician perspectivesAlice Tunks, Martha Piper, Sean Humfrey, et al.
The Journal of Infection|June 2, 2020
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort studyJames B Galloway, Sam Norton, Richard D Barker, et al.
Plos One|January 13, 2022
Inpatient COVID-19 mortality has reduced over time: Results from an observational cohortKatie Bechman, Mark Yates, Kirsty Mann, et al.
Pageof 31